What does GENEXPERT do?

GENEXPERT is a specialist medical practice in Ittre. Private Limited, started on 3 April 2002, 1 establishment.

What is the address of GENEXPERT?

The registered office of GENEXPERT is located at Rue Emile Montoisy 4, 1460 Ittre.

Is GENEXPERT still active?

Yes. According to the CBE (29 October 2026) GENEXPERT is active, legal situation “Normale toestand”, started on 3 April 2002.

Is GENEXPERT registered on Peppol?

Yes, GENEXPERT is registered on the Peppol network with ID 0208:0477248809.

What is the enterprise number of GENEXPERT?

The enterprise number of GENEXPERT is BE0477248809.

When was GENEXPERT founded?

GENEXPERT was founded on 3 April 2002.

Who are the directors of GENEXPERT?

According to the 2025 annual accounts, the directors of GENEXPERT are: Bruno NERINCX.

Is GENEXPERT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 April 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GENEXPERT make in 2025?

GENEXPERT posted a profit after taxes of € 23,889 in financial year 2025.

What is the revenue of GENEXPERT?

As a small company, GENEXPERT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 50,868.

GENEXPERT (Private Limited) - Ittre - BE0477248809

Dossier GENEXPERT, printed on 29 October 2026 from databakkes.be/en/0477248809/genexpert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GENEXPERT from Ittre, company number BE0477248809, closed financial year 2025 with a result of € 23,889 after tax. For that financial year GENEXPERT recorded a gross margin of € 50,868 and equity of € 207,208. Compared with financial year 2024, the result moved from € 42,306 to € 23,889. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 207,208

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 23,889

▼ 44% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 95,152

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 122,808.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 42,324

▼ 14% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,728

▼ 97% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,458

▼ 20% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -10,641 Gross margin 2022: € -10,641 First fiscal year in the series	€ -7,655 Gross margin 2023: € -7,655 ▲ € 2,985 vs 2022 (€ -10,641) Favourable step	€ 59,347 Gross margin 2024: € 59,347 ▲ € 67,003 vs 2023 (€ -7,655) Favourable step	€ 50,868 Gross margin 2025: € 50,868 ▼ 14% vs 2024 (€ 59,347) Unfavourable step	▼ 14%
Profit after taxes	€ -49,277 Profit after taxes 2022: € -49,277 First fiscal year in the series	€ -10,404 Profit after taxes 2023: € -10,404 ▲ € 38,872 vs 2022 (€ -49,277) Favourable step	€ 42,306 Profit after taxes 2024: € 42,306 ▲ € 52,711 vs 2023 (€ -10,404) Favourable step	€ 23,889 Profit after taxes 2025: € 23,889 ▼ 44% vs 2024 (€ 42,306) Unfavourable step	▼ 44%
Equity	€ 168,650 Equity 2022: € 168,650 First fiscal year in the series	€ 158,245 Equity 2023: € 158,245 ▼ 6% vs 2022 (€ 168,650) Unfavourable step	€ 183,319 Equity 2024: € 183,319 ▲ 16% vs 2023 (€ 158,245) Favourable step	€ 207,208 Equity 2025: € 207,208 ▲ 13% vs 2024 (€ 183,319) Favourable step	▲ 13%
Total debts	€ 40,670 Total debts 2022: € 40,670 First fiscal year in the series	€ 32,880 Total debts 2023: € 32,880 ▼ 19% vs 2022 (€ 40,670) Favourable step	€ 95,230 Total debts 2024: € 95,230 ▲ 190% vs 2023 (€ 32,880) Unfavourable step	€ 17,819 Total debts 2025: € 17,819 ▼ 81% vs 2024 (€ 95,230) Favourable step	▼ 81%
Cash	€ 169,755 Cash 2022: € 169,755 First fiscal year in the series	€ 134,041 Cash 2023: € 134,041 ▼ 21% vs 2022 (€ 169,755) Unfavourable step	€ 123,526 Cash 2024: € 123,526 ▼ 8% vs 2023 (€ 134,041) Unfavourable step	€ 95,152 Cash 2025: € 95,152 ▼ 23% vs 2024 (€ 123,526) Unfavourable step	▼ 23%
Retained profit	€ 84,250 Retained profit 2022: € 84,250 First fiscal year in the series	€ 73,845 Retained profit 2023: € 73,845 ▼ 12% vs 2022 (€ 84,250) Unfavourable step	€ 98,919 Retained profit 2024: € 98,919 ▲ 34% vs 2023 (€ 73,845) Favourable step	€ 122,808 Retained profit 2025: € 122,808 ▲ 24% vs 2024 (€ 98,919) Favourable step	▲ 24%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 17,233 Dividend 2024: € 17,233 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 17,233) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 453 Bank debt 2023: € 453 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 453) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 209,319 Balance sheet total 2022: € 209,319 First fiscal year in the series	€ 191,125 Balance sheet total 2023: € 191,125 ▼ 9% vs 2022 (€ 209,319) Unchanged	€ 278,549 Balance sheet total 2024: € 278,549 ▲ 46% vs 2023 (€ 191,125) Unchanged	€ 225,027 Balance sheet total 2025: € 225,027 ▼ 19% vs 2024 (€ 278,549) Unchanged	▼ 19%

Key figures of GENEXPERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GENEXPERT?

What happened at GENEXPERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 23,889 (▼ 44% vs 2024). filed late Source: NBB ↗
2023 Bruno NERINCX became a director. NBB
Apr 3, 2002 Start of the company according to the CBE. KBO
Mar 26, 2002 New establishment in Ittre. KBO

In short

From € 49,277 loss in 2022 to € 23,889 profit in 2025.

Paid € 17,137 in corporate taxes since 2022.

Best year ever: 2024, with € 42,306 profit.

Paid out € 17,233 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bruno NERINCX

GENEXPERT

Behind GENEXPERT is Bruno NERINCX.

Directors

According to the 2025 annual accounts

Bruno NERINCX

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Emile Montoisy 4

1460 Ittre

2.229.159.176

Rue de Fauquez 27

1460 Ittre

Active since 26 March 2002

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0477.248.809

VAT number

BE 0477.248.809

Registered office

Rue Emile Montoisy 4, 1460 Ittre

Names & denominations

GENEXPERT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 April 2002

Peppol

Active · Active since 25 Nov 2025

Activities · NACE

Activiteiten van medisch specialisten

Teelt van pit- en steenvruchten

Vakantieverblijven en andere accommodatie voor kort verblijf, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

GENEXPERT

Financials

What happened to GENEXPERT?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions